General - Press Releases

Date	Title	Company
11-Jan-2022	Flora Growth Completes Successful First Cannabis Extraction Through New Facility, Initiates EU-GMP Certification Process	Businesswire
11-Jan-2022	Verastem Oncology Outlines Key 2022 Strategic Priorities and Upcoming Catalysts for Advancing VS-6766 as a Backbone of Therapy for RAS Pathway-Driven Cancers	Businesswire
11-Jan-2022	Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan	Businesswire
11-Jan-2022	Erica Mawby-Roche Joins Termeer Foundation as Newly-Appointed Director, Termeer Fellows Program	Businesswire
11-Jan-2022	Arlington Capital Partners Announces the Acquisition of Millstone Medical Outsourcing	Businesswire
11-Jan-2022	Takeda unterstreicht Strategie für nachhaltiges Wachstum in den nächsten zehn Jahren auf der 40. jährlichen J.P. Morgan Healthcare Conference	Businesswire
11-Jan-2022	Riassunto: Alla 40esima edizione annuale del Convegno sull’assistenza sanitaria organizzato da J.P. Morgan, Takeda sottolinea la strategia finalizzata a conseguire una crescita sostenibile nel prossimo decennio	Businesswire
11-Jan-2022	Alpha Blue Ocean Group Announces New Financing Worth €8 Million With Safe Orthopaedics	Businesswire
11-Jan-2022	Takeda enfatiza estratégia para oferecer crescimento sustentável na próxima década na 40ª Conferência Anual de Saúde da J.P. Morgan	Businesswire
11-Jan-2022	European Commission Approves KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat Children With Cystic Fibrosis Ages 6 to 11 Years	Businesswire
11-Jan-2022	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
11-Jan-2022	FDA Pre-Submission Filed for Cardio inCode-SCORE	Newswire
11-Jan-2022	Takeda übernimmt Adaptate Biotherapeutics zur Entwicklung neuartiger Gamma-delta-(γδ)-T-Zell-Engager-Therapien gegen solide Tumore	Businesswire
11-Jan-2022	Samenvatting: Toezichthouders keuren Impella 5.5 met SmartAssist goed in Japan en Hongkong; US FDA verleent voorwaardelijke IDE-goedkeuring voor Impella BTR voor eerste-humanstudie naar vroege haalbaarheid	Businesswire
11-Jan-2022	Riassunto: Approvata a livello normativo Impella 5.5 con SmartAssist in Giappone e a Hong Kong; la FDA statunitense concede a Impella BTR l'approvazione condizionale IDE per il primo studio di fattibilità precoce su soggetti umani	Businesswire
10-Jan-2022	Riassunto: Takeda rileverà Adaptate Biotherapeutics per sviluppare nuove terapie basate su T-cell engager Gamma Delta (γδ) mirate ai tumori solidi	Businesswire
10-Jan-2022	ZIVO Bioscience Names Chairman John B. Payne as President and CEO	Businesswire
10-Jan-2022	Labcorp to Announce Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022	Businesswire
10-Jan-2022	Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40th Annual J.P. Morgan Healthcare Conference	Businesswire
10-Jan-2022	Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development	Businesswire